A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the March 7 2013 issue of Nature by Prof Dimmler, Boon, and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Small molecule therapy for Myocardial Infarction: Fiestin, a Flavonoid enriched in strawberries, improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10). By treating people with Fiestin, one may prevent ageing-associated decline in cardiac function. Together, this study suggests, for the first time, that pharmacological formulations encompassing “Fiestin or its analogues” may be used to improve cardiac function after myocardial infarction.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Small molecule therapy for Myocardial Infarction: Fiestin, a Flavonoid enriched in strawberries, improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 20/September/2014, 04.50 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
